Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

commercialization

6 posts
RRoche
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
Read More

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

  • 2026-07-06
Nurix Therapeutics, Inc. Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted…
RRoche
Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg
Read More

Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg

  • 2026-06-12
Roche RHHBY has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics NRIX to co-develop and…
RRoche
Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg
Read More

Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg

  • 2026-06-10
Roche RHHBY has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics NRIX to co-develop and…
RRoche
Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg
Read More

Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg

  • 2026-06-08
Roche RHHBY has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics NRIX to co-develop and…
UUBS
Read More

Repeat Purchase Rate Is Top Indicator to Evaluate Humanoid Robot Industry, UBS Analyst Says

  • 2026-05-20
(Yicai) May 20 — Despite record growth in shipments and financing amount last year, the better indicator to…
NNovartis
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
Read More

SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease

  • 2026-03-15
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…
Switzerland
www.europesays.com